TNF-α and IL-1β induced SPATA2 expression in ovarian cancer cells and that increased SPATA2 expression was associated with poor prognosis of ovarian cancer patients (Wieser et al., 2019). This evidence concerns the gene SPATA2 and ovarian cancer.